Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.52
+0.38 (3.17%)
At close: Sep 9, 2025, 4:00 PM
12.28
-0.24 (-1.88%)
After-hours: Sep 9, 2025, 6:13 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $351.08 million as of September 9, 2025. Its market cap has decreased by -25.17% in one year.
Market Cap
351.08M
Enterprise Value
181.35M
1-Year Change
-25.17%
Ranking
Category
Stock Price
12.52
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $351.08M, a decrease of -12.69%. That is a compound annual growth rate of -9.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 351.08M | -7.03% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |